Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis
Susana García‐Recio(University of North Carolina at Chapel Hill), Lisa A. Carey(University of North Carolina at Chapel Hill), Uma Chandran(UPMC Hillman Cancer Center), Rita Nanda(University of Chicago), Julie M. Gastier‐Foster(Nationwide Children's Hospital), Youli Xia(University of North Carolina at Chapel Hill), Markia A. Smith(University of North Carolina at Chapel Hill), Carey K. Anders(Duke Medical Center), Marni B. McClure(University of North Carolina at Chapel Hill), Hui Shen(Van Andel Institute), Andrea L. Richardson(Johns Hopkins University), Fergus J. Couch(Mayo Clinic), Melinda E. Sanders(Vanderbilt University), Aguirre A. de Cubas(Medical University of South Carolina), Ezgi Karaesmen(Nationwide Children's Hospital), Ana C. Garrido-Castro(Dana-Farber Cancer Institute), Brooke Felsheim(University of North Carolina at Chapel Hill), Antonio C. Wolff(Johns Hopkins University), Toshinori Hinoue(University of Southern California), Minetta C. Liu(Mayo Clinic), Paula I. González-Ericsson(Breast Cancer Research Foundation), Benjamin Kelly(Nationwide Children's Hospital), Ian E. Krop(Yale Cancer Center), Larry Norton(Memorial Sloan Kettering Cancer Center), Tomás Pascual(Breast Cancer Research Foundation), Nancy E. Davidson(WinnMed), Gregory Wheeler(Mississippi State University), Jay Bowen(Nationwide Children's Hospital), Nancy U. Lin(Dana-Farber Cancer Institute), Chad J. Creighton(Baylor College of Medicine), Anna Maria Storniolo(Indiana University Health), Joel S. Parker(University of North Carolina at Chapel Hill), Robyn Burns(Breast Cancer Research Foundation), Sara E. Coppens(Nationwide Children's Hospital), Amy Wheless(University of North Carolina at Chapel Hill), P. Kelly Marcom(Duke University), Michael A. Davis(Southwest Research Institute), Claudine Isaacs(Georgetown University), Andrei Rajkovic(Nationwide Children's Hospital), Mothaffar F. Rimawi(Baylor College of Medicine), Susan G. Hilsenbeck(Baylor College of Medicine), Jonathan C. Silverstein(University of Pittsburgh), Kelly K. Foy(Van Andel Institute), Ben Ho Park(Vanderbilt University Medical Center), Alexander J. Ropelewski(Pittsburgh Supercomputing Center), Salma Rezk(University of North Carolina at Chapel Hill), Kristen Leraas(University of California, San Francisco), Amy Garrett(University of North Carolina at Chapel Hill), W. Fraser Symmans(The University of Texas MD Anderson Cancer Center)
Cited by 114
Related Papers
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
|Neoplasia|2017|6.5k
Comprehensive molecular characterization of gastric adenocarcinoma
|Nature|2014|6.5k
The Immune Landscape of Cancer
|Immunity|2018|6.2k
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
|Journal of Clinical Oncology|1997|5.9k